Detection of the WT1 transcript by RT-PCR in complete remission has no prognostic relevance in de novo acute myeloid leukemia

Leukemia

Volumn 12, Issue 12, 1998, Pages 1886-1894

  Gaiger, A ^a   Schmid, D ^a   Heinze, G ^a   Linnerth, B ^a   Greinix, H ^a   Kalhs, P ^a   Tisljar, K ^a   Priglinger, S ^a   Laczika, K ^a   Mitterbauer, M ^a   Novak, M ^a   Mitterbauer, G ^b   Mannhalter, C ^b   Haas, O A ^c   Lechner, K ^a   Jager U ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

Acute myeloid leukemia; Minimal residual disease; PCR; Prognostic factors; WT1

Indexed keywords

CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MESSENGER RNA; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RETINOIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANALYTICAL EQUIPMENT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA REMISSION; MALE; MINIMAL RESIDUAL DISEASE; NEPHROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

EID: 17344368789     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401213     Document Type: Article

References (9)

1. Claxton DF, Liu P, Hsu HP, Marlton P, Hester J, Collins F, Deisseroth AB, Rowley JD, Siciliano MJ. Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia. Blood 1994; 83: 1750-1756.
2. Novak M, Laczika K, Mitterbauer M, Purtscher B, Scheidel-Petrovic A, Lechner K, Jaeger U, Haas OA. Novel CBFβ-MYH11 fusion transcripts and alternative splicing in acute myeloid leukemia with inversion of chromosome 16. Blood 1995; 86: 2449-2450 (letter).
3. Hébert J, Cayuela JM, Daniel MT, Berger R, Sigaux F. Detection of minimal residual disease in acute myelomonocytic leukemia with abnormal marrow eosinophils by nested polymerase chain reaction with allele specific amplification. Blood 1994; 84: 2291-2296.
4. Kusec R, Laczika K, Knöbl P, Friedl J, Greinix H, Kalhs P, Linkesch W, Schwarzinger I, Mitterbauer G, Purtscher B, Haas O, Lechner K, Jaeger U. AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation. Leukemia 1994; 8: 735-739.
5. Jurlander J, Caligiuri MA, Ruutu T, Baer MR, Strout MP, Oberkircher AR, Hoffmann L, Ball ED, Frei-Lahr DA, Christiansen NP, Block AW, Knuutila S, Herzig GP, Bloomfield CD. Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia. Blood 1996; 88: 2183-2191.
6. Laczika K, Mitterbauer G, Korninger L, Knöbl P, Schwarzinger I, Kapiotis S, Haas OA, Kyrle PA, Pont J, Oehler L, Purtscher B, Thalhammer F, Lechner K, Häger U. Rapid achievement of PML/RARα polymerase chain reaction (PCR)-negativity by combined treatment with all-trans retinoic acid and chemotherapy in acute promyelocytic leukemia: a pilot study. Leukemia 1994; 8: 1-5.
7. Estey E, Keating MJ, Pierce S, Stass S. Change in karyotype between diagnosis and first relapse in acute myelogenous leukemia. Leukemia 1995; 9: 972-976.
8. Miwa H, Beran M, Saunders GF. Expression of the Wilms' tumor gene (WT1) in human leukemias. Leukemia 1992; 6: 405-409.
9. Brieger J, Weidmann E, Maurer U, Hölzer D, Mitrou PS, Bergmann L. The Wilms' tumor gene is frequently expressed in acute myeloblastic leukemias and may provide a marker for residual blast cells detectable by PCR. Ann Oncol 1995; 6: 811-816.